Echinacoside

DB15488InvestigationalSmall molecule

Echinacoside is a phenylethanoid glycoside plant isolate currently being investigated for anti-apoptotic and neuroprotective effects. Echinacoside has demonstrated inhibition of apoptosis in neural cell lines, demonstrating potential for use in the treatment of neurological conditions.

Mechanism: The neuroprotective effects are thought to be mediated via effects on mitogen-activated protein kinase, nuclear factor kappa-B, caspases 3 and 8, as well as CHOP pathways.
Curator reviewed · 1 reference
Formula / weight: C₃₅H₄₆O₂₀ · 786.733 g/mol (avg)

Resolves to

Compound

UNIII04O1DT48TCAS82854-37-3ChEMBLCHEMBL510539ChEBI4745KEGGC10450

Structure

InChIKeyFSBUXLDOLNLABB-ISAKITKMSA-NSMILES

C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](OCCC3=CC(O)=C(O)C=C3)O[C@H](CO[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H]2OC(=O)\C=C\C2=CC(O)=C(O)C=C2)[C@H](O)[C@H](O)[C@H]1O

Targets

Q92847GHSRP10275AR

What you can answer from here — as of April 02, 2025

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

6Drug interactionsStructured to mechanism, not free text

1Clinical trialPhase, status and sponsor resolved per trial

8+ReferencesStructured and connected to the statements they support

Which drugs share a target with Echinacoside, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account